Text Size

Venous Thrombosis in Turner Syndrome

The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2008 by University of Aarhus.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of Aarhus
ClinicalTrials.gov Identifier:
NCT00594763
First received: January 7, 2008
Last updated: January 31, 2008
Last verified: January 2008
History of Changes
  Purpose

In the literature, cases of thrombosis in the venous system have been described in girls and women with Turner syndrome. By screening a group of women with Turner syndrome, the researchers wish to find out if this condition is more frequent in this patient population.


Condition
Thromboembolic Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Risk of Venous Thrombosis in Women With Turner Syndrome

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by University of Aarhus:

Biospecimen Retention:   Samples With DNA

Blood


Estimated Enrollment: 60
Study Start Date: June 2006
Estimated Study Completion Date: April 2008
Estimated Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Groups/Cohorts
TS
Women with Turner syndrome

Detailed Description:

In the literature cases of thrombosis in the venous system has been described in girls and women with Turner syndrome. By screening a group of women with Turner syndrome we wish to find out if this condition is more frequent in this patient population. Participants are examined with screening blood tests evaluating thromboembolic disturbances.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Women with Turner syndrome

Criteria

Inclusion Criteria:

  • Turner syndrome verified by karyotyping
  • Aged 18 or above

Exclusion Criteria:

  • Malignant disease
  • Treatment with anticoagulants
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00594763

Locations
Denmark
Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital
Aarhus, Aarhus C, Denmark, 8000
Sponsors and Collaborators
University of Aarhus
Investigators
Principal Investigator: Jens Sandahl Christiansen, MD, dr.med, professor Medical Department of Endocrinology, Aarhus University Hospital, 8000 Aarhus, Denmark
  More Information

No publications provided

Responsible Party: Jens Sandahl Christiansen, Aarhus University Hospital, Aarhus, Denmark
ClinicalTrials.gov Identifier: NCT00594763     History of Changes
Other Study ID Numbers: 20050045
Study First Received: January 7, 2008
Last Updated: January 31, 2008
Health Authority: Denmark: Ethics Committee

Keywords provided by University of Aarhus:
Turner syndrome
Thromboembolic disease

Additional relevant MeSH terms:
Thromboembolism
Thrombosis
Turner Syndrome
Gonadal Dysgenesis
Primary Ovarian Insufficiency
Venous Thrombosis
Venous Thromboembolism
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Disorders of Sex Development
Urogenital Abnormalities
Sex Chromosome Disorders of Sex Development
 Heart Defects, Congenital
Cardiovascular Abnormalities
Heart Diseases
Congenital Abnormalities
Sex Chromosome Disorders
Chromosome Disorders
Genetic Diseases, Inborn
Gonadal Disorders
Endocrine System Diseases
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female

ClinicalTrials.gov processed this record on May 22, 2013